• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ustekinumab in Treatment of Refractory Paediatric Crohn Disease.

作者信息

Cameron F L, Garrick V, Russell R K

机构信息

*Child Life and Health, University of Edinburgh, Edinburgh†Paediatric Gastroenterology, Royal Hospital for Sick Children, Glasgow, UK.

出版信息

J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):e30. doi: 10.1097/MPG.0000000000000608.

DOI:10.1097/MPG.0000000000000608
PMID:26910458
Abstract
摘要

相似文献

1
Ustekinumab in Treatment of Refractory Paediatric Crohn Disease.优特克单抗治疗难治性儿童克罗恩病
J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):e30. doi: 10.1097/MPG.0000000000000608.
2
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.在使用英夫利昔单抗治疗克罗恩病期间出现银屑病头皮伴脱发，且两病均对乌司奴单抗快速起效。
Eur Rev Med Pharmacol Sci. 2013 Oct;17(20):2831-6.
3
Combination treatment with monoclonal antibodies: Dupilumab and ustekinumab for the treatment of severe atopic dermatitis and Crohn disease.单克隆抗体联合治疗：度普利尤单抗和优特克单抗用于治疗重度特应性皮炎和克罗恩病。
Australas J Dermatol. 2024 Feb;65(1):63-66. doi: 10.1111/ajd.14185. Epub 2023 Nov 6.
4
Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.难治性肿瘤坏死因子抑制剂诱导的掌跖脓疱病的治疗：2例报告
Arch Dermatol. 2011 Oct;147(10):1228-30. doi: 10.1001/archdermatol.2011.275.
5
Ustekinumab.优特克单抗
MAbs. 2009 May-Jun;1(3):216-21. doi: 10.4161/mabs.1.3.8593.
6
Demyelination in a patient receiving ustekinumab for refractory Crohn's disease.
J Crohns Colitis. 2014 Sep;8(9):1138-9. doi: 10.1016/j.crohns.2014.02.004. Epub 2014 Feb 23.
7
Ustekinumab: moving the target from psoriasis to Crohn's disease.乌司奴单抗：将治疗靶点从银屑病转向克罗恩病。
Expert Rev Gastroenterol Hepatol. 2014 Jan;8(1):5-13. doi: 10.1586/17474124.2014.850414. Epub 2013 Nov 25.
8
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].[优特克单抗治疗克罗恩病合并抗TNF-α诱导的银屑病1例]
Gastroenterol Hepatol. 2011 Oct;34(8):546-50. doi: 10.1016/j.gastrohep.2011.04.003. Epub 2011 Jun 12.
9
Update on ustekinumab for the treatment of Crohn's disease.优特克单抗治疗克罗恩病的最新进展
Gastroenterol Clin North Am. 2014 Sep;43(3):619-30. doi: 10.1016/j.gtc.2014.05.013.
10
Letter: ustekinumab for the treatment of post-surgical and refractory Crohn's disease.信函：优特克单抗用于治疗术后及难治性克罗恩病。
Aliment Pharmacol Ther. 2021 Apr;53(7):859-860. doi: 10.1111/apt.16281.

引用本文的文献

1
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.STEP-CD 研究：乌司奴单抗在儿童克罗恩病中的应用——来自 ESPGHAN 儿童 IBD 波尔图小组的多中心回顾性研究。
Eur J Pediatr. 2024 Aug;183(8):3253-3262. doi: 10.1007/s00431-024-05588-2. Epub 2024 May 3.
2
New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease.极早发型炎症性肠病发病机制与治疗的新见解和进展
Front Pediatr. 2022 Mar 1;10:714054. doi: 10.3389/fped.2022.714054. eCollection 2022.
3
Ustekinumab for the treatment of refractory pediatric Crohn's disease: a single-center experience.
优特克单抗治疗难治性儿童克罗恩病：单中心经验
Intest Res. 2021 Apr;19(2):217-224. doi: 10.5217/ir.2019.09164. Epub 2020 Apr 22.
4
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.加拿大胃肠病学协会儿童局限性克罗恩病医学管理临床实践指南
J Can Assoc Gastroenterol. 2019 Aug;2(3):e35-e63. doi: 10.1093/jcag/gwz018. Epub 2018 Jul 10.
5
Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center.在一家三级儿童炎症性肠病护理中心，乌司奴单抗在儿童和青年中的真实世界应用经验。
J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):61-67. doi: 10.1097/MPG.0000000000002362.
6
Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.治疗克罗恩病的新一代生物制剂：关于优特克单抗的循证综述
Clin Exp Gastroenterol. 2017 Nov 15;10:293-301. doi: 10.2147/CEG.S110546. eCollection 2017.